Special Issue "Serological Studies on SARS-CoV-2 and COVID-19 Infection"

A special issue of Diseases (ISSN 2079-9721). This special issue belongs to the section "Infectious Disease".

Deadline for manuscript submissions: 30 April 2022.

Special Issue Editor

Dr. Massimo Pieri
E-Mail Website
Guest Editor
Department of Experimental Medicine, University of Tor Vergata, Rome, Italy
Interests: clinical biochemistry; quality management; instrument validation; biomarkers; neuroscience; neurodegenerative diseases; patch-clamp experiments for studying electrical activity (voltage clamp, current clamp, and dynamic clamp)

Special Issue Information

Dear Colleagues,

Since the end of 2019, a novel coronavirus, named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has spread all over the world, leading to coronavirus disease 2019 (COVID-19) causing serious public health events and huge losses to global health and the economy. Due to its rapid spread and strong infectivity, it is necessary to diagnose and treat patients with different clinical manifestations and suspected patients as soon as possible to reduce the risk of death and control the spread of the virus.

This Special Issue “Serological Studies on SARS-CoV-2 and COVID-19 Infection” aims to focus on the cutting-edge serological research related to SARS-CoV-2 and the COVID-19 pandemic. Specific topics include but are not limited to testing method and technology developments, the diagnostics of the virus, identification of new variants of the virus, results of laboratory statistics, and interesting cases of patients with COVID-19. Manuscripts addressing other relevant and challenging problems are also strongly encouraged.

We cordially invite researchers working in this field to contribute original research articles, short communications, and critical review articles. Short papers on one compound will also be welcome.

Dr. Massimo Pieri
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diseases is an international peer-reviewed open access quarterly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • SARS-CoV-2
  • Serological tests
  • Receptor binding domain
  • Immune response
  • Angiotensin-converting enzyme II

Published Papers

This special issue is now open for submission.
Back to TopTop